FDA Briefing materials for the September 26, 2019 Joint Meeting of the Pediatric and Drug Safety Risk Management Advisory Committees
- FDA Briefing Document
- Oxycontin® (oxycodone hydrochloride) Labeling
- Oxycontin® (oxycodone hydrochloride) Clinical Review
- Oxycontin® (oxycodone hydrochloride) Clinical Pharmacology Review
- Oxycontin® (oxycodone hydrochloride) Statistical Review